A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.

N, Kobyliak; L, Abenavoli; G, Mykhalchyshyn; L, Kononenko; L, Boccuto; D, Kyriienko; O, Dynnyk

doi:10.15403/jgld.2014.1121.271.kby

Public

A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.

Shared by NobleBlocks on Mar 1, 2018 • 12:00 AM UTC

Authors:

Kobyliak N

Abenavoli L

Mykhalchyshyn G

Abstract

Background Probiotics have a beneficial effect on nonalcoholic fatty liver disease (NAFLD) in animal models. Randomized placebo-controlled trials (RCTs) in NAFLD are still lacking in humans despite a large number of data from animal research.Aim We performed a double-blind single center RCT of live ...

Discussions